The University of Maryland School of Medicine Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is recruiting an outstanding Ph.D., M.D., or M.D./Ph.D. tumor immunologist (Assistant, Associate, or Full Professor) who has an active federally-funded research program. Competitive start-up and salary packages are available. The successful candidates are expected to maintain a productive and funded research program focused on tumor immunology, mentor students, post-doctoral associates and/or physician scientists, present their work at national meetings, publish in peer-reviewed journals, and participate in collaborative research efforts. The appointees will have opportunities to develop and sustain collaborative relationships with basic and clinical researchers, and clinicians within the UMGCCC and School of Medicine. The UMGCCC recently completed construction of a state-of-the-art cellular therapeutics laboratory that has the capacity to produce cell-based and cancer vaccine immunotherapies for patients. This Laboratory also provides the infrastructure for translational vaccine/cellular immunotherapy studies and our established CAR-T, transplant, and cellular therapy clinical and research programs. For senior professor candidates, substantial opportunities for leadership and program building are available.
Applicants should reference position #03-303-047 and send a letter of interest, CV, and the names of 3 references to:
Ms. Florence Wade
University of Maryland
Marlene & Stewart Greenebaum Cancer Center
The University of Maryland, Baltimore is an Equal Opportunity, Affirmative Action employer. Minorities, women, individuals with disabilities, and protected veterans are encouraged to apply.